Japanese firm Santen Pharmaceutical Co., Ltd. and US based Orbis International have announced a partnership to develop a suite of digital training tools that will continue to help eye care professionals around the world build their skills.

Through the three-year, global partnership, Orbis and Santen will create online courses, live surgical demonstrations, and artificial intelligence (AI) focused on glaucoma, a leading cause of avoidable blindness.

The digital tools will be available in Chinese, providing a best-in-class, standardized teaching curriculum in that language. The collaboration will utilize Orbis’s award-winning telemedicine platform, Cybersight, which has some 25,000 users across 199 countries.

Through this partnership, Santen, a global leader in ophthalmology with a strong focus in glaucoma, can enable access to these distant learning tools for more eye care professionals, especially in remote rural areas.

By adding to the growing body of educational resources available in languages beyond English, Santen and Orbis aim to expand the number of eye care professionals who can benefit from the platform.